Position in BIIB
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$475,332
+$464,248 QoQ
Shares Held
2,200
+2616.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#582
of 1,036 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. BIIB ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
This page
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $475,332 | 2,200 | Shares | Defined | 2026-07-15 | |
| 2025-03-31 | $11,084 | 81 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $12,386 | 81 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $15,701 | 81 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $18,777 | 81 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $17,466 | 81 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $20,960 | 81 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $20,817 | 81 | Shares | Sole | 2023-11-21 | |
| No filing history on record for this holder in this stock. | ||||||